Trials / Completed
CompletedNCT02730468
SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 350 (actual)
- Sponsor
- Karius, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the performance of the Karius Infectious Diseases Plasma Sequencing Assay in patients who present to the emergency room with sepsis.
Conditions
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2017-09-01
- Completion
- 2017-10-01
- First posted
- 2016-04-06
- Last updated
- 2017-10-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02730468. Inclusion in this directory is not an endorsement.